Orchid Pharma signs licensing, supply pact with Russia’s Pharmasyntez for Exblifep

Shares of Orchid Pharma Ltd ended at ₹926.05, down by ₹6.55, or 0.70%, on the BSE.

Leave a Reply

Your email address will not be published. Required fields are marked *